Insider · CIK 0002033155
Bethany J Cavanagh
cfoofficer
Files at BEAM (Beam Therapeutics Inc.). First filing Jan 6, 2025, latest Oct 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $627k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BEAM: Beam Therapeutics Inc.
BEAMOct 9, 2026 · close 25.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 2Weak | Beam Therapeutics Inc. | $4,565 187 shares | -0% | +18% from low-36% from high | |
| 34Weak | Beam Therapeutics Inc. | $217k 6,198 shares | -15% | +136% from low-3% from high | |
| 26Weak | Beam Therapeutics Inc. | $91k 3,034 shares | -7% | +113% from low-13% from high | |
| 17Weak | Beam Therapeutics Inc. | $11k 467 shares | -1% | +66% from low-29% from high | |
| 24Weak | Beam Therapeutics Inc. | $55k 3,015 shares | -6% | 0% from low-48% from high | |
| 27Weak | Beam Therapeutics Inc. | $220k 6,287 shares | -14% | - | |
| 15Weak | Beam Therapeutics Inc. | $28k 1,117 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -187 | $24.41 | $4,565 | 50,984 | 10 d ago |
| Jan 31, 2026 | BEAM Beam Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 2, 2026 |
| Jan 22, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -6,198 | $35.00 | $217k | 34,813 | Jan 26, 2026 |
| Jan 20, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -3,034 | $30.12 | $91k | 41,011 | Jan 21, 2026 |
| Oct 1, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -467 | $24.53 | $11k | 44,045 | Oct 3, 2025 |
| Apr 1, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -3,015 | $18.35 | $55k | 44,512 | Apr 3, 2025 |
| Mar 31, 2025 | BEAM Beam Therapeutics Inc. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 47,527 | Apr 2, 2025 |
| Feb 18, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -6,287 | $35.00 | $220k | 37,527 | Feb 20, 2025 |
| Jan 31, 2025 | BEAM Beam Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Feb 3, 2025 |
| Jan 2, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -1,117 | $24.68 | $28k | 43,814 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.